Technology | June 09, 2008

Coronary Dilatation Catheter Scores with Angioplasty


OrbusNeich's Scoreflex coronary dilatation catheter, which is only CE Mark approval, but not yet FDA cleared, is a new product that extends OrbusNeich's balloon catheter portfolio.

Scoreflex is designed for use in focused force angioplasty, a technique in which the force resulting from balloon inflation in a stenotic lesion is concentrated at one or more locations within the stenosis. Published research has shown that focused force angioplasty is effective in resolving resistant stenosis, while reducing the frequency of complications with its use of gradual, low-pressure inflations.

The Scoreflex dual wire system creates a focal stress pattern to facilitate effective controlled plaque fracture at low-resolution pressure. In addition to its effective dilatation, Scoreflex has a low crossing profile and unbeatable trackability.


Additional Content

News | Catheters

Nov. 4, 2026 — Evident Vascular has announced U.S. Food and Drug Administration (FDA) 510(k) clearance of the Evident ...

Home November 05, 2026
Home
News | Catheters

Sept. 14, 2026 — Interventional Medical Device Solutions (IMDS), has announced the U.S. launch of NHanceIT, an over-the ...

Home September 15, 2026
Home
News | Catheters

June 30, 2026 — Penumbra Inc. has received the CE Mark for Red 72 Silver Label and Red 72 Silver Label with SENDit ...

Home July 02, 2026
Home
News | Catheters

Feb. 12, 2026 – CellProthera has acquired the transendocardial catheter originally developed by Celyad Oncology. This ...

Home February 12, 2026
Home
News | Catheters

Oct. 23, 2025— Emboline, Inc., a provider of full-body embolic protection devices for transcatheter procedures, thas ...

Home October 28, 2025
Home
Subscribe Now